Gliocart
1 known investors
GlioCART develops a dual-action CAR-T cell therapy for glioblastoma that targets tumor cells while reprogramming tumor-supporting myeloid cells into active immune effectors. The company aims to extend CAR-T therapy to solid tumors and other myeloid-driven cancers.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Gliocart do?
- GlioCART develops a dual-action CAR-T cell therapy for glioblastoma that targets tumor cells while reprogramming tumor-supporting myeloid cells into active immune effectors. The company aims to extend CAR-T therapy to solid tumors and other myeloid-driven cancers.
- Who are Gliocart's investors?
- Gliocart's investors include Kickfund.